Skip to main content

Advertisement

ADVERTISEMENT

Volume 24 - Issue 10 - October 2012

Feature

Original Contribution
10/01/2012

*Peter Damman, MD1, *Mohamed Abdel-Wahab, MD2, Helge Möllmann, MD3, Gert Richardt, MD2, Bernard Chevalier, MD4, Paul Barragan, MD5, Jan G.P. Tijssen, PhD1, Paul Underwood, MD6, Christian W. Hamm, MD3

*Peter Damman, MD1, *Mohamed Abdel-Wa...
Abstract: Objectives. We compared safety and efficacy outcomes of 3 limus-based drug-eluting stents in the ‘all-comers’ PROENCY (PROmus/ENdeavor /CYpher) registry. Background. Limited data are available on head-to-head comparisons of the...
Abstract: Objectives. We compared safety and efficacy outcomes of 3 limus-based drug-eluting stents in the ‘all-comers’ PROENCY (PROmus/ENdeavor /CYpher) registry. Background. Limited data are available on head-to-head comparisons of the...
Abstract: Objectives. We...
10/01/2012
Journal of Invasive Cardiology
Original Contribution
10/01/2012

Teruyoshi Kume, MD, PhD1, Katsuhisa Waseda, MD, PhD1, Bon-Kwon Koo, MD, PhD1, Roberto Botelho, MD2, Stefan Verheye, MD, PhD3, Robert Whitbourn, MD4, Ian Meredith, MD, PhD5, Stephen Worthley, MD, PhD6, Koh Tian Hai, MD7, Paul G. Yock, MD1, Flavio Roberto Azevedo de Oliveira, MD, PhD8, Alexandre Abizaid, MD, PhD8, Peter J. Fitzgerald, MD, PhD1, Yasuhiro Honda, MD1

Teruyoshi Kume, MD, PhD1, Katsuhisa W...
Abstract: Background. The Sparrow stent system (Biosensors International) consists of a self-expanding, ultra-thin nitinol stent mounted within a 0.014˝ guidewire designed for small or tortuous coronary lesions. We compared the intravascular...
Abstract: Background. The Sparrow stent system (Biosensors International) consists of a self-expanding, ultra-thin nitinol stent mounted within a 0.014˝ guidewire designed for small or tortuous coronary lesions. We compared the intravascular...
Abstract: Background. The...
10/01/2012
Journal of Invasive Cardiology
Original Contribution
10/01/2012

Bimmer E. Claessen, MD, PhD1,2, Alaide Chieffo, MD3, George D. Dangas, MD, PhD1,4, Cosmo Godino, MD3, Seung-Whan Lee, MD5, Kotaro Obunai, MD1, Mauro Carlino, MD3, Vaso Chantziara, MD6, Irini Apostolidou, MD6, José P.S. Henriques, MD, PhD2, Martin B. Leon, MD1,6, Carlo Di Mario, MD, PhD7, Seung-Jung Park, MD5, Gregg W. Stone, MD1,6, Jeffrey W. Moses, MD1,6, Antonio Colombo, MD3, Roxana Mehran, MD1,4, on behalf of the Multinational CTO Registry

Bimmer E. Claessen, MD, PhD1,2, Alaid...
Abstract: Introduction. Little is known about gender differences among patients undergoing percutaneous coronary intervention (PCI) for chronic total occlusion (CTO). Methods. A total of 1791 patients with 1852 CTOs underwent PCI at 3 centers...
Abstract: Introduction. Little is known about gender differences among patients undergoing percutaneous coronary intervention (PCI) for chronic total occlusion (CTO). Methods. A total of 1791 patients with 1852 CTOs underwent PCI at 3 centers...
Abstract: Introduction. Little...
10/01/2012
Journal of Invasive Cardiology
Original Contribution
10/01/2012

Masami Nishino, MD, PhD, Yasuharu Lee, MD, Daisuke Nakamura, MD, Takahiro Yoshimura, MD, Masayuki Taniike, MD, PhD, Nobuhiko Makino, MD, PhD, Hiroyasu Kato, MD, Yasuyuki Egami, MD, Ryu Shutta, MD, Jun Tanouchi, MD, PhD, Yoshio Yamada, MD, PhD

Masami Nishino, MD, PhD, Yasuharu Lee...
Abstract: Aim. In-stent restenosis (ISR), especially focal ISR, after percutaneous coronary intervention (PCI) remains one of the major clinical problems in the drug-eluting stent (DES) era. Several reports have revealed that excimer laser...
Abstract: Aim. In-stent restenosis (ISR), especially focal ISR, after percutaneous coronary intervention (PCI) remains one of the major clinical problems in the drug-eluting stent (DES) era. Several reports have revealed that excimer laser...
Abstract: Aim. In-stent...
10/01/2012
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement